Home/Filings/4/0001209191-19-047959
4//SEC Filing

PHILLIPS CHARLES G III 4

Accession 0001209191-19-047959

CIK 0001645113other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:22 PM ET

Size

12.8 KB

Accession

0001209191-19-047959

Insider Transaction Report

Form 4
Period: 2019-08-30
Transactions
  • Sale

    Ordinary Shares

    2019-08-30$90.63/sh8,692$787,73922,812 total
  • Exercise/Conversion

    Ordinary Shares

    2019-08-30$6.72/sh+22,000$147,84031,504 total
  • Sale

    Ordinary Shares

    2019-08-30$91.46/sh12,908$1,180,5409,904 total
  • Sale

    Ordinary Shares

    2019-08-30$92.10/sh400$36,8399,504 total
  • Exercise/Conversion

    Options to Buy Ordinary Shares

    2019-08-3022,00040,607 total
    Exercise: $6.72Exp: 2022-09-28Ordinary Shares (22,000 underlying)
Footnotes (4)
  • [F1]On August 30, 2019, Mr. Phillips sold 8,692 shares in multiple trades at prices ranging from $89.92 to $90.91. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]On August 30, 2019, Mr. Phillips sold 12,908 shares in multiple trades at prices ranging from $90.93 to $91.92. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]On August 30, 2019, Mr. Phillips sold 400 shares in multiple trades at prices ranging from $91.95 to $92.27. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Fully vested as of the date hereof.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001129246

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:22 PM ET
Size
12.8 KB